Diverse factors affect management

Article

Factors as disparate as ocular blood flow, beta blockers, and sleep apnea all may play roles in the development and progression of glaucoma.

According to Dr. Semes, ocular blood flow as relevant to glaucoma cannot universally be evaluated with any single blood flow imaging device. Therefore, with the current state of the art, assessing perfusion to the optic nerve and inner retina is done indirectly. A comprehensive approach using multiple imaging technologies is required for meaningful insight.

"It's important to remember that the eye has multiple vascular beds and a segmental blood supply," Dr. Semes said. "Although the majority of blood flow to the optic nerve head is derived from the choroidal plexus, you can't just look at retinal blood flow, you can't just look at choroidal blood flow, and you can't just look at blood flow to the optic nerve head."

"It may be that approaches that reduce blood pressure or increase blood flow, such as exercise, are equally good for the eyes as they are for the heart," Dr. Semes said.

Dr. Semes added that it's important to look at perfusion pressure to the optic nerve head, especially in patients in whom glaucoma is progressing even though their intraocular pressure (IOP) is at the target level. To determine the diastolic ocular perfusion pressure (DOPP), subtract the patient's mean IOP from his or her mean systemic diastolic blood pressure. A DOPP above 55 generally means a lower risk of ocular nerve damage.1

"This is something we're still getting our arms around," Dr. Semes said. "Measuring perfusion pressure isn't as entrenched as measuring IOP, but it's an important emerging area."

Evaluate beta blocker use

Dr. Semes said that maintaining an adequate ocular perfusion pressure is why he urges caution when using topical beta blockers at night.

"Low blood pressure at night, coupled with high IOP in the supine position, can compromise ocular perfusion pressure," he said. "Patients who are using topical beta blockers at night may be reducing their IOP, but they also may be reducing perfusion to the optic nerve head. This is because systemic absorption of the drops, from the blood vessels on the surface of the eye, may be depressing blood pressure systemically."

Instead of using beta blockers twice a day, Dr. Semes recommends having patients use the beta blocker in the morning and a prostaglandin analog (PGA) at night when the PGA is insufficient. "To minimize nocturnal hypotension, avoid IOP meds that lower systemic blood pressure at night, such as beta blockers and alpha agonists," he said. This advice has been suggested previously, and is particularly important in normal tension glaucoma.2

Recent Videos
Katie Rachon, OD, FAAO, Dipl ABO, shares her excitement for the upcoming conference and what it means for an optometrist's toolbox.
EnVision Summit Cochair Cecelia Koetting, OD, FAAO, Dipl ABO, says that attendees should get ready for more discussion-based panels at this year's conference.
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
Bonnie An Henderson in an interview for the EnVision Summit
From new treatments on the horizon for macular degeneration to strengthening comanagement ties, optometrists cite a lot to be excited about in the coming year.
EnVision Summit cofounder and program chair Dr Bonnie Henderson chats about collaborative eye care
Practice owners testify to the importance of trying new things, not being afraid to fail, and utilizing community as a resource when starting up a new practice.
Bonnie An Henderson in an interview for the EnVision Summit
© 2025 MJH Life Sciences

All rights reserved.